Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OKYO | AMGN | VRTX | REGN | GILD |
| Company | Okyo Pharma Limited ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.2200 | 310.25 | 469.76 | 1,046.28 | 68.50 |
| High | 1.2200 | 312.43 | 477.93 | 1,046.28 | 68.50 |
| Low | 1.1900 | 307.64 | 467.41 | 1,046.28 | 68.50 |
| Last | 1.2100 | 312.00 | 475.38 | 1,042.25 | 68.12 |
| Change | -0.0300 | +1.23 | +1.60 | -2.41 | -0.28 |
| % Change | -2.42% | +0.40% | +0.34% | -0.23% | -0.41% |
| Volume | 7,000 | 1,542,800 | 852,500 | 461 | 778 |
| 20-Day Average Volume | 8,830 | 2,432,280 | 1,282,940 | 459,213 | 8,998,472 |
| Previous Close | 1.2400 | 311.01 | 471.25 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2766 | 307.73 | 475.85 | 1,037.44 | 66.74 |
| 20-Day Raw Stochastic | 30.77% | 50.19% | 45.48% | 61.83% | 61.24% |
| 20-Day Relative Strength | 43.11% | 55.86% | 60.54% | 61.60% | 54.89% |
| Weighted Alpha | -28.04 | +36.35 | +41.72 | +47.67 | -10.23 |
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Previous Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | 40% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.31% since 06/25/24 | -2.67% since 06/25/24 | -0.01% since 06/25/24 | -2.14% since 06/26/24 | -1.17% since 06/26/24 |
| Low | 1.1100 on 06/27/24 | 307.64 on 07/02/24 | 467.41 on 07/02/24 | 1,030.23 on 07/02/24 | 67.58 on 07/02/24 |
| High | 1.2800 on 07/01/24 | 319.00 on 07/01/24 | 481.14 on 06/26/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | -18.79% since 05/31/24 | +1.61% since 05/31/24 | +4.05% since 05/31/24 | +5.74% since 06/03/24 | +7.99% since 06/03/24 |
| Low | 1.0900 on 06/25/24 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 1.4800 on 06/12/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -16.57% since 04/02/24 | +12.51% since 04/02/24 | +15.72% since 04/02/24 | +10.02% since 04/03/24 | -3.37% since 04/03/24 |
| Low | 1.0900 on 06/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.5800 on 05/17/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | -37.63% since 01/02/24 | +4.50% since 01/02/24 | +15.30% since 01/02/24 | +14.03% since 01/03/24 | -17.94% since 01/03/24 |
| Low | 1.0900 on 06/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 1.9500 on 01/08/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,887 | 166,707,904 | 122,260,352 | 115,106,896 | 85,216,352 |
| Shares Outstanding, K | 28,832 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -13,270,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | -0.04 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/20/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.69 | 31.29 | 28.48 | 17.03 |